Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112339) titled 'A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Novo Nordisk A/S
Condition:
Diabetes Mellitus, Type 2
Intervention:
Drug: Insulin icodec
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: August 5, 2025
Target Sample Size: 586
Countries of Recruitment:
Canada
Germany
Italy
Canada
Germany
Ital...